Minghui Pharmaceutical (hangzhou) Ltd

This study tested an experimental ointment called MH004 in 160 healthy adults and people with mild to moderate atopic dermatitis (eczema). The goal was to see if the ointment is safe and can reduce eczema severity. Researchers measured skin improvement and side effects over sever…

This study tested an ointment called MH004 in 375 people aged 12 and older with mild to moderate eczema (atopic dermatitis). The goal was to see if it safely clears or nearly clears skin within 4 to 8 weeks. Participants applied the ointment or a placebo cream, and those who join…